Cost-effectiveness of dapagliflozin plus standard treatment compared to standard therapy for the management of chronic kidney disease in Colombia [0.03%]
达格列净联合标准治疗与单一标准治疗用于哥伦比亚慢性肾脏病患者管理的成本效益分析
Pieralessandro Lasalvia,Eliana C Vásquez M,Jose Javier Arango Álvarez et al.
Pieralessandro Lasalvia et al.
Background: The DAPA-CKD study showed that dapagliflozin added to standard treatment reduced the risk of chronic kidney disease progression, and death from renal or cardiovascular causes compared to placebo. ...
Cost of long-term care and balancing caregiver wellbeing: a narrative review [0.03%]
长期护理的成本和平衡照料者的健康状况：叙述性综述
Emeka Elvis Duru,Kenechukwu C Ben-Umeh,T Joseph Mattingly
Emeka Elvis Duru
Introduction: Long-term care (LTC) refers to care and support services that are required by individuals who lack the ability to perform important daily routines and may be dependent on others for personal, social, and med...
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial [0.03%]
ASTRUM-004试验为基础的赛普利单抗联合化疗用于中国晚期肺鳞癌一线治疗的成本效益分析
Heng Xiang,Kehui Meng,Meiyu Wu et al.
Heng Xiang et al.
Objective: In the ASTRUM-004 trial, serplulimab plus chemotherapy demonstrated significantly improved survival and controllable safety. This study assessed the cost-effectiveness of serplulimab plus chemotherapy in advanc...
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer in the Chinese healthcare system [0.03%]
帕博利珠单抗联合化疗对比安慰剂联合化疗用于中国HER2阴性晚期胃癌和食管胃交界处癌患者的成本效益分析
Wenwang Lang,Lian Deng,Meijun Lu et al.
Wenwang Lang et al.
Background: This study compares first-line pembrolizumab plus chemotherapy with chemotherapy alone for patients with HER2-negative advanced gastric cancer (GC) and gastroesophageal junction cancer (GEJC) in China. ...
Pembrolizumab combined with chemotherapy versus placebo combined with chemotherapy for HER2-negative advanced gastric cancer in China: a cost-effectiveness analysis [0.03%]
帕博利珠单抗联合化疗对比安慰剂联合化疗治疗中国HER2阴性晚期胃癌的成本效益分析
Zhiwei Zheng,Xiaobing Song,Hongfu Cai et al.
Zhiwei Zheng et al.
Objective: This study aims to conduct a cost-effectiveness analysis of pembrolizumab in combination with chemotherapy for HER2-negative advanced gastric cancer in China. ...
Bridging the gap: enhancing medication adherence through research and innovation [0.03%]
缩小差距：通过研究和创新提高药物依从性
Tamás Ágh,Mickaël Hiligsmann
Tamás Ágh
Adherence to oral anticoagulants in patients with non-valvular atrial fibrillation: the role of patients' characteristics and out-of-pocket payments [0.03%]
非瓣膜性房颤患者口服抗凝药的依从性：患者的特征和自付费用的作用
Siraj Al-Obaidi,Rima Hijazeen,Rasha M Arabyat et al.
Siraj Al-Obaidi et al.
Background: Recent practice guidelines favor direct oral anticoagulants (DOACs) over warfarin for primary stroke prevention in patients with non-valvular atrial fibrillation (NVAF). However, challenges persist in Iraq's p...
Mapping the World Health Organization Disability Assessment Scale 2.0 to the EQ-5D-5L in patients with mental disorders [0.03%]
精神疾病患者的WHO残疾评估表2.0至EQ-5D-5L的映射关系研究
Edimansyah Abdin,Vanessa Seet,Anitha Jeyagurunathan et al.
Edimansyah Abdin et al.
Objective: The current study aims to develop an algorithm for mapping the WHODAS 2.0 to the EQ-5D-5 L for patients with mental disorders. Methods: ...
Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study [0.03%]
利益相关者视角下的患者参与数字化依从性技术的研发和实施研究
Dalma Hosszú,Alexandra L Dima,Francisca Leiva Fernández et al.
Dalma Hosszú et al.
Background: This study aims to create a comprehensive framework for the development and implementation of digital medication adherence technologies (DMATech), focusing on critical stages where engagement of medication use...
How can physicians improve medication adherence and outcomes in dermatological conditions? [0.03%]
医师如何改善皮肤病患者的药物顺应性及治疗效果？
Jessica Q Duong,Ryan F Bloomquist,Steven R Feldman
Jessica Q Duong
Introduction: Medication non-adherence is a major contributor to suboptimal disease treatment across medical specialties and is a particular hurdle with topicals. While adherence is a patient behavior affected by many soc...